OCEAW
Income statement / Annual
Last year (2024), Ocean Biomedical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Ocean Biomedical, Inc.'s net income was -$3.30 M.
See Ocean Biomedical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$26.00 K
|
$0.00
|
$33.93 M
|
$49.00 K
|
$35.00 K
|
| General & Administrative Expenses |
$3.77 M
|
$0.00
|
$28.41 M
|
$1.60 M
|
$197.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.77 M
|
$2.48 M
|
$28.41 M
|
$1.60 M
|
$197.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
-$61.78 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.80 M
|
$2.48 M
|
$566.56 K
|
$1.65 M
|
$232.00 K
|
| Cost And Expenses |
$0.00
|
$2.48 M
|
$566.56 K
|
$1.65 M
|
$232.00 K
|
| Interest Income |
$0.00
|
$1.52 M
|
$2.45 K
|
$0.00
|
$0.00
|
| Interest Expense |
-$2.05 M
|
$691.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$236.56 K
|
$206.30 K
|
$171.86 K
|
| EBITDA |
$0.00 |
-$957.74 K |
-$327.55 K |
-$1.65 M |
-$232.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$1.52 M
|
$2.45 K
|
-$1.00 K
|
$0.00
|
| Income Before Tax |
-$3.30 M
|
-$958.43 K
|
-$564.11 K
|
-$1.65 M
|
-$232.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$3.30 M
|
$565.47 K
|
-$62.34 M
|
-$1.65 M
|
-$232.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.12 |
-0.0474 |
-0.0426 |
-0.0818 |
-0.0115 |
| EPS Diluted |
-0.12 |
-0.0474 |
-0.0426 |
-0.0818 |
-0.0115 |
| Weighted Average Shares Out |
$27.50 M
|
$19.02 M
|
$13.23 M
|
$20.20 M
|
$20.20 M
|
| Weighted Average Shares Out Diluted |
$27.50 M
|
$19.02 M
|
$13.23 M
|
$20.20 M
|
$20.20 M
|
| Link |
|
|
|
|
|
